Literature DB >> 19224711

It takes guts for tolerance: the phenomenon of oral tolerance and the regulation of autoimmune response.

Jean Pierre Schatzmann Peron1, Ana Paula Ligeiro de Oliveira, Luiz Vicente Rizzo.   

Abstract

The intestinal tract is a peculiar environment due to its constant contact with the microbiota agents, food antigens and other molecules. Such exposure requires the establishment of important regulatory mechanisms in order to avoid inflammatory response and self aggression. In this context, the GALT plays a very relevant role due to the presence of several different cellular populations which are the main players in this phenomenon. Moreover, it was described a while ago that the oral ingestion of a given molecule is able to induce systemic tolerance to the same molecule when it is used as an immunogen by parenteral route, known as oral tolerance. This observation led researches to use these mechanisms to induce tolerance against cognate antigens of different autoimmune diseases. In this context, in this review we focused on several tolerance inducing mechanisms which are relevant not only for the maintenance of intestinal tract but also for the suppression of T effector cells, such as Th1, Th2 and the newly described Th17 cells. To name a few, CD103(+) dendritic cells, Tr1 cells derived IL-10 secretion, Foxp3 conversion and CD4(+)LAP(+) regulatory cells induction are among the recently described features of the tolerogenic environment of the intestinal tract. 2009 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224711     DOI: 10.1016/j.autrev.2009.02.024

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  14 in total

1.  Human endometrial-derived mesenchymal stem cells suppress inflammation in the central nervous system of EAE mice.

Authors:  J P S Peron; T Jazedje; W N Brandão; P M Perin; M Maluf; L P Evangelista; S Halpern; M G Nisenbaum; C E Czeresnia; M Zatz; N O S Câmara; L V Rizzo
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  A contemporary update on scleroderma.

Authors:  Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

3.  Reproductive immunology: current status and future directions (part I).

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

Review 4.  Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications.

Authors:  Barbara L Shacklett; Ruth M Greenblatt
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

5.  The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.

Authors:  D S Vinay; B S Kwon
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

6.  IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2.

Authors:  Bing Zhu; Thomas Buttrick; Ribal Bassil; Chen Zhu; Marta Olah; Chuan Wu; Sheng Xiao; William Orent; Wassim Elyaman; Samia J Khoury
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

Review 7.  Mechanism of oral tolerance induction to therapeutic proteins.

Authors:  Xiaomei Wang; Alexandra Sherman; Gongxian Liao; Kam W Leong; Henry Daniell; Cox Terhorst; Roland W Herzog
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

Review 8.  On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota.

Authors:  Elena Gianchecchi; Alessandra Fierabracci
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 9.  Mechanisms of Oral Tolerance.

Authors:  Scott P Commins
Journal:  Pediatr Clin North Am       Date:  2015-09-07       Impact factor: 3.278

Review 10.  Gastrointestinal function development and microbiota.

Authors:  Antonio Di Mauro; Josef Neu; Giuseppe Riezzo; Francesco Raimondi; Domenico Martinelli; Ruggiero Francavilla; Flavia Indrio
Journal:  Ital J Pediatr       Date:  2013-02-24       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.